Toll-like receptor 4 methylation grade is linked to depressive symptom severity.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
24 06 2021
Historique:
received: 07 10 2020
accepted: 11 05 2021
revised: 27 04 2021
entrez: 6 7 2021
pubmed: 7 7 2021
medline: 15 7 2021
Statut: epublish

Résumé

This study explores potential associations between the methylation of promoter-associated CpG sites of the toll-like receptor (TLR)-family, plasma levels of pro-inflammatory proteins and depressive symptoms in young female psychiatric patients. Ratings of depressive symptoms and blood samples were obtained from 92 young women seeking psychiatric care. Methylation of 32 promoter-associated CpG sites in TLR1 to TLR10 was analysed using the Illumina Infinium Methylation EPIC BeadChip. Expression levels of 91 inflammatory proteins were determined by proximity extension assay. Statistical correlations between depressive state, TLR1-10 methylation and inflammatory proteins were investigated. Four additional cohorts were studied to evaluate the generalizability of the findings. In the discovery cohort, methylation grade of cg05429895 (TLR4) in blood was inversely correlated with depressive symptoms score in young adults. After correction for multiple testing, plasma levels of macrophage inflammatory protein 1β (MIP-1β/CCL4) were associated with both TLR4 methylation and depressive symptom severity. A similar inverse association between TLR4 methylation in blood and affective symptoms score was also found in a cohort of 148 both males and females (<40 years of age) from the Danish Twin Registry. These findings were not, however, replicated in three other external cohorts; which differed from the first two cohorts by a higher age and mixed ethnicities, thus limiting the generalizability of our findings. However, TLR4 methylation inversely correlated with TLR4 mRNA expression in the Danish Twin Study indicating a functional significance of methylation at this particular CpG. Higher depression scores in young Scandinavian adults was associated with decreased methylation of TLR4 in blood.

Identifiants

pubmed: 34226490
doi: 10.1038/s41398-021-01481-w
pii: 10.1038/s41398-021-01481-w
pmc: PMC8257733
doi:

Substances chimiques

TLR4 protein, human 0
Toll-Like Receptor 4 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

371

Références

Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–57.
pubmed: 23902484 doi: 10.1056/NEJMra1201534
Brambillaambilla P, Bellani M, Isola M, Bergami A, Marinelli V, Dusi N, et al. Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia. Transl Psychiatry. 2014;4:e406–e406.
doi: 10.1038/tp.2014.46
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.
pubmed: 26711676 pmcid: 5542678 doi: 10.1038/nri.2015.5
Drago A, Crisafulli C, Calabro M, Serretti A. Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder. J Affect Disord. 2015;179:88–94.
pubmed: 25855618 doi: 10.1016/j.jad.2015.03.032
Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–86.
pubmed: 19188531 doi: 10.1097/PSY.0b013e3181907c1b
Mostafavi S, Battle A, Zhu X, Potash JB, Weissman MM, Shi J, et al. Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry. 2014;19:1267–74.
pubmed: 24296977 doi: 10.1038/mp.2013.161
Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98:477–504.
pubmed: 29351513 doi: 10.1152/physrev.00039.2016
Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med. 2005;257:156–66.
pubmed: 15656874 doi: 10.1111/j.1365-2796.2004.01442.x
Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci. 2001;933:222–34.
pubmed: 12000023 doi: 10.1111/j.1749-6632.2001.tb05827.x
Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012;73:1128–38.
pubmed: 22967776 doi: 10.4088/JCP.12r07694
Figueroa-Hall LK, Paulus MP, Savitz J. Toll-like receptor signaling in depression. Psychoneuroendocrinology 2020;121:104843.
pubmed: 32911436 doi: 10.1016/j.psyneuen.2020.104843 pmcid: 7883590
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
pubmed: 16497588 doi: 10.1016/j.cell.2006.02.015
Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61:1013–21.
pubmed: 12430718 doi: 10.1093/jnen/61.11.1013
Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–76.
pubmed: 12524386 doi: 10.1146/annurev.immunol.21.120601.141126
Hung YY, Kang HY, Huang KW, Huang TL. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res. 2014;220:283–6.
pubmed: 25155940 doi: 10.1016/j.psychres.2014.07.074
Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010;24:64–71.
pubmed: 19666104 doi: 10.1016/j.bbi.2009.08.001
McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry. 2011;1:e36–e36.
pubmed: 22832610 pmcid: 3309507 doi: 10.1038/tp.2011.37
Oliveira J, et al. Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders. PLoS One 2015;10:e0119702.
pubmed: 25790282 pmcid: 4366110 doi: 10.1371/journal.pone.0119702
Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA. 2007;104:13798–803.
pubmed: 17693552 pmcid: 1959462 doi: 10.1073/pnas.0702553104
Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011;34:269–81.
pubmed: 21419501 pmcid: 3095763 doi: 10.1016/j.tins.2011.02.005
Kawai T, Akira S. TLR signaling. Semin Immunol. 2007;19:24–32.
pubmed: 17275323 doi: 10.1016/j.smim.2006.12.004
Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, Cruz-Fuentes C, Reyes-Grajeda JP, García-Cuétara Mdel P, et al. The immune system and the role of inflammation in perinatal depression. Neurosci Bull. 2016;32:398–420.
pubmed: 27432060 pmcid: 5563787 doi: 10.1007/s12264-016-0048-3
Liu J, Buisman-Pijlman F, Hutchinson MR. Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front Neurosci. 2014;8:309.
pubmed: 25324715 pmcid: 4179746 doi: 10.3389/fnins.2014.00309
Garcia Bueno B, Caso JR, Madrigal JL, Leza JC. Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci Biobehav Rev. 2016;64:134–47.
pubmed: 26905767 doi: 10.1016/j.neubiorev.2016.02.013
Gárate I, García-Bueno B, Madrigal JL, Bravo L, Berrocoso E, Caso JR, et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation. 2011;8:151.
pubmed: 22053929 pmcid: 3219571 doi: 10.1186/1742-2094-8-151
Strekalova T, Evans M, Costa-Nunes J, Bachurin S, Yeritsyan N, Couch Y, et al. Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet. Brain Behav Immun. 2015;48:42–7.
pubmed: 25712260 doi: 10.1016/j.bbi.2015.02.015
Perrouderroud N, Paoloni-Giacobino A, Prada P, Olié E, Salzmann A, Nicastro R, et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry. 2011;1:e59–e59.
doi: 10.1038/tp.2011.60
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33–41.
pubmed: 23201972 doi: 10.1038/nn.3275
Kim D, Kubzansky LD, Baccarelli A, Sparrow D, Spiro A, Tarantini L, et al. Psychological factors and DNA methylation of genes related to immune/inflammatory system markers: the VA normative aging study. BMJ Open. 2016;6:e009790.
pubmed: 26733571 pmcid: 4716233 doi: 10.1136/bmjopen-2015-009790
Dalton VS, Kolshus E, McLoughlin DM. Epigenetics and depression: return of the repressed. J Affect Disord. 2014;155:1–12.
pubmed: 24238955 doi: 10.1016/j.jad.2013.10.028
Chan RF, Turecki G, Shabalin AA, Guintivano J, Zhao M, Xie LY, et al. Cell type-specific methylome-wide association studies implicate neurotrophin and innate immune signaling in major depressive disorder. Biol Psychiatry. 2020;87:431–42.
pubmed: 31889537 doi: 10.1016/j.biopsych.2019.10.014
Gárate I, García-Bueno B, Madrigal JL, Caso JR, Alou L, Gómez-Lus ML, et al. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation. 2014;11:8.
pubmed: 24410883 pmcid: 3897306 doi: 10.1186/1742-2094-11-8
Tramullas M, Finger BC, Moloney RD, Golubeva AV, Moloney G, Dinan TG, et al. Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice. Biol Psychiatry. 2014;76:340–8.
pubmed: 24331544 doi: 10.1016/j.biopsych.2013.11.004
Cattaneo A, Macchi F, Plazzotta G, Veronica B, Bocchio-Chiavetto L, Riva MA, et al. Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis. Front Cell Neurosci. 2015;9:40.
pubmed: 25873859 pmcid: 4379909 doi: 10.3389/fncel.2015.00040
Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696–709.
pubmed: 26903267 pmcid: 6056174 doi: 10.1038/mp.2016.3
Benson S, et al. Effects of acute systemic inflammation on the interplay between sad mood and affective cognition. Transl Psychiatry. 2017;7:1281.
DellaGioia N, Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev. 2010;34:130–43.
pubmed: 19666048 doi: 10.1016/j.neubiorev.2009.07.014
Karshikoff B, Lekander M, Soop A, Lindstedt F, Ingvar M, Kosek E, et al. Modality and sex differences in pain sensitivity during human endotoxemia. Brain Behav Immun. 2015;46:35–43.
pubmed: 25486090 doi: 10.1016/j.bbi.2014.11.014
Benson S, Elsenbruch S. No reason to feel sick? nocebo responses in the placebo arms of experimental endotoxemia studies. Front Psychiatry. 2019;10:511.
pubmed: 31379627 pmcid: 6652147 doi: 10.3389/fpsyt.2019.00511
Lasselin J, Elsenbruch S, Lekander M, Axelsson J, Karshikoff B, Grigoleit JS, et al. Mood disturbance during experimental endotoxemia: Predictors of state anxiety as a psychological component of sickness behavior. Brain Behav Immun. 2016;57:30–7.
pubmed: 26790758 doi: 10.1016/j.bbi.2016.01.003
Martinez-Muniz GA, Wood SK. Sex differences in the inflammatory consequences of stress: implications for pharmacotherapy. J Pharm Exp Ther. 2020;375:161–74.
doi: 10.1124/jpet.120.266205
Knight EL, Majd M, Graham-Engeland JE, Smyth JM, Sliwinski MJ, Engeland CG. Gender differences in the link between depressive symptoms and ex vivo inflammatory responses are associated with markers of endotoxemia. Brain Behav Immun Health. 2020;2:100013.
doi: 10.1016/j.bbih.2019.100013 pubmed: 34258602 pmcid: 8274590
Cunningham JL, Zanzi M, Willebrand M, Ekselius L, Ramklint M. No regrets: young adult patients in psychiatry report positive reactions to biobank participation. BMC Psychiatry. 2017;17:21.
pubmed: 28095825 pmcid: 5240261 doi: 10.1186/s12888-017-1199-0
Sheehan DV, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;5922-33;quiz 4-57.
First MSRG M, Williams J. Structured clinical interview for DSM-IV axis I disorders, Clinician Version (SCID-CV). Washington: American Psychiatric Press;; 1996.
Svanborg P, Asberg M. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord. 2001;64:203–16.
pubmed: 11313087 doi: 10.1016/S0165-0327(00)00242-1
Price ME, Cotton AM, Lam LL, Farré P, Emberly E, Brown CJ, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin. 2013;6:4.
pubmed: 23452981 pmcid: 3740789 doi: 10.1186/1756-8935-6-4
Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 2014;15:R37.
pubmed: 24555846 pmcid: 4053980 doi: 10.1186/gb-2014-15-2-r37
Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013;8:203–9.
pubmed: 23314698 pmcid: 3592906 doi: 10.4161/epi.23470
Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinforma. 2012;13:86.
doi: 10.1186/1471-2105-13-86
Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014;30:1363–9.
pubmed: 24478339 pmcid: 4016708 doi: 10.1093/bioinformatics/btu049
Triche TJ Jr., Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of illumina infinium DNA methylation BeadArrays. Nucleic Acids Res. 2013;41:e90–e90.
pubmed: 23476028 pmcid: 3627582 doi: 10.1093/nar/gkt090
Schalkwyk LC, et al. Illumina 450 methylation array normalization and metrics. Package ‘wateRmelon’. 2013.
Fortin JP, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:503.
pubmed: 25599564 pmcid: 4283580 doi: 10.1186/s13059-014-0503-2
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27.
pubmed: 16632515 doi: 10.1093/biostatistics/kxj037
Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9:e95192.
pubmed: 24755770 pmcid: 3995906 doi: 10.1371/journal.pone.0095192
Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39:e102–e102.
pubmed: 21646338 pmcid: 3159481 doi: 10.1093/nar/gkr424
Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinforma. 2010;11:587.
doi: 10.1186/1471-2105-11-587
Frost M, Petersen I, Brixen K, Beck-Nielsen H, Holst JJ, Christiansen L, et al. Adult glucose metabolism in extremely birthweight-discordant monozygotic twins. Diabetologia. 2012;55:3204–12.
pubmed: 22955993 doi: 10.1007/s00125-012-2695-x
Pedersen DA, Larsen LA, Nygaard M, Mengel-From J, McGue M, Dalgård C, et al. The Danish Twin registry: an updated overview. Twin Res Hum Genet. 2019;22:499–507.
pubmed: 31544734 pmcid: 8039015 doi: 10.1017/thg.2019.72
McGue M, Christensen K. Genetic and environmental contributions to depression symptomatology: evidence from Danish twins 75 years of age and older. J Abnorm Psychol. 1997;106:439–48.
pubmed: 9241945 doi: 10.1037/0021-843X.106.3.439
Soerensen M, Li W, Debrabant B, Nygaard M, Mengel-From J, Frost M, et al. Epigenome-wide exploratory study of monozygotic twins suggests differentially methylated regions to associate with hand grip strength. Biogerontology. 2019;20:627–47.
pubmed: 31254144 pmcid: 6733812 doi: 10.1007/s10522-019-09818-1
Nygaard M, Larsen MJ, Thomassen M, McGue M, Christensen K, Tan Q, et al. Global expression profiling of cognitive level and decline in middle-aged monozygotic twins. Neurobiol Aging. 2019;84:141–7.
pubmed: 31585296 doi: 10.1016/j.neurobiolaging.2019.08.019
Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209–13.
pubmed: 2423876 doi: 10.1038/321209a0
Yu L, Wang J, Wang S, Zhang D, Zhao Y, Wang R, et al. DNA methylation regulates gene expression in intracranial aneurysms. World Neurosurg. 2017;105:28–36.
pubmed: 28433851 doi: 10.1016/j.wneu.2017.04.064
Kim TW, Lee SJ, Oh BM, Lee H, Uhm TG, Min JK, et al. Epigenetic modification of TLR4 promotes activation of NF-kappaB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. Oncotarget. 2016;7:4195–209.
pubmed: 26675260 doi: 10.18632/oncotarget.6549
Guo MM, Chang LS, Huang YH, Wang FS, Kuo HC. Epigenetic regulation of macrophage marker expression profiles in Kawasaki disease. Front Pediatr. 2020;8:129.
pubmed: 32309269 pmcid: 7145949 doi: 10.3389/fped.2020.00129
Cheng Y, Jope RS, Beurel E. A pre-conditioning stress accelerates increases in mouse plasma inflammatory cytokines induced by stress. BMC Neurosci. 2015;16:31.
pubmed: 25947540 pmcid: 4425917 doi: 10.1186/s12868-015-0169-z
Cheng Y, Pardo M, Armini RS, Martinez A, Mouhsine H, Zagury JF, et al. Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain Behav Immun. 2016;53:207–22.
pubmed: 26772151 pmcid: 4783243 doi: 10.1016/j.bbi.2015.12.012
Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001;2:1126–32.
pubmed: 11702067 doi: 10.1038/ni735
Perrin-Cocon L, Aublin-Gex A, Sestito SE, Shirey KA, Patel MC, André P, et al. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection. Sci Rep. 2017;7:40791.
pubmed: 28106157 pmcid: 5247753 doi: 10.1038/srep40791
Schwacha MG, Zhang Q, Rani M, Craig T, Oppeltz RF. Burn enhances toll-like receptor induced responses by circulating leukocytes. Int J Clin Exp Med. 2012;5:136–44.
pubmed: 22567174 pmcid: 3342708
Duenas AI, Orduna A, Crespo MS, Garcia-Rodriguez C. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int Immunol. 2004;16:1467–75.
pubmed: 15339879 doi: 10.1093/intimm/dxh148
Smedman C, Ernemar T, Gudmundsdotter L, Gille-Johnson P, Somell A, Nihlmark K, et al. FluoroSpot analysis of TLR-activated monocytes reveals several distinct cytokine-secreting subpopulations. Scand J Immunol. 2012;75:249–58.
pubmed: 21955279 pmcid: 3321223 doi: 10.1111/j.1365-3083.2011.02641.x
Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res. 2002;69:94–103.
pubmed: 12111820 doi: 10.1002/jnr.10253
Sindhu S, Kochumon S, Shenouda S, Wilson A, Al-Mulla F, Ahmad R. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20:18.
doi: 10.3390/ijms20184658
Xiong GL, Prybol K, Boyle SH, Hall R, Streilein RD, Steffens DC, et al. Inflammation markers and major depressive disorder in patients with chronic heart failure: results from the sertraline against depression and heart disease in chronic heart failure study. Psychosom Med. 2015;77:808–15.
pubmed: 26186432 pmcid: 4565768 doi: 10.1097/PSY.0000000000000216
Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23:48–58.
pubmed: 29133955 doi: 10.1038/mp.2017.205
Bekhbat M, Neigh GN. Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety. Brain Behav Immun. 2018;67:1–12.
pubmed: 28216088 doi: 10.1016/j.bbi.2017.02.006
Zhang K, Lin W, Zhang J, Zhao Y, Wang X, Zhao M. Effect of Toll-like receptor 4 on depressive-like behaviors induced by chronic social defeat stress. Brain Behav. 2020;10:e01525.
pubmed: 31945269 pmcid: 7066327 doi: 10.1002/brb3.1525
Gárate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus ML, et al. Stress-induced neuroinflammation: role of the toll-like receptor-4 pathway. Biol Psychiatry. 2013;73:32–43.
pubmed: 22906518 doi: 10.1016/j.biopsych.2012.07.005
Just D, et al. Autoantibodies against the C-terminus of Lipopolysaccharide binding protein are elevated in young adults with psychiatric disease. Psychoneuroendocrinology. 2021;126. https://doi.org/10.1016/j.psyneuen.2021.105162
Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, Jiang XC, et al. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res. 2003;44:1489–98.
pubmed: 12754273 doi: 10.1194/jlr.M200440-JLR200
Takahashi K, Sugi Y, Nakano K, Tsuda M, Kurihara K, Hosono A, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011;286:35755–62.
pubmed: 21862578 pmcid: 3195625 doi: 10.1074/jbc.M111.271007
Ganança L, Oquendo MA, Tyrka AR, Cisneros-Trujillo S, Mann JJ, Sublette ME. The role of cytokines in the pathophysiology of suicidal behavior. Psychoneuroendocrinology. 2016;63:296–310.
pubmed: 26546783 doi: 10.1016/j.psyneuen.2015.10.008
Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT. The role of inflammation in suicidal behaviour. Acta Psychiatr Scand. 2015;132:192–203.
pubmed: 26256862 pmcid: 4531386 doi: 10.1111/acps.12458
Bryleva EY, Brundin L. Suicidality and activation of the kynurenine pathway of tryptophan metabolism. Curr Top Behav Neurosci.2017;31:269–84.
pubmed: 27221623 doi: 10.1007/7854_2016_5
Pandey GN, Rizavi HS, Ren X, Bhaumik R, Dwivedi Y. Toll-like receptors in the depressed and suicide brain. J Psychiatr Res. 2014;53:62–8.
pubmed: 24565447 pmcid: 4004369 doi: 10.1016/j.jpsychires.2014.01.021
Peedicayil J. The role of epigenetics in mental disorders. Indian J Med Res. 2007;126:105–11.
pubmed: 17932433
Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:261–8.
pubmed: 16526044 doi: 10.1002/ajmg.b.30272
Leenen FA, Muller CP, Turner JD. DNA methylation: conducting the orchestra from exposure to phenotype? Clin Epigenetics. 2016;8:92.
pubmed: 27602172 pmcid: 5012062 doi: 10.1186/s13148-016-0256-8
Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients—findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res. 2009;43:215–29.
pubmed: 18586274 doi: 10.1016/j.jpsychires.2008.05.002
Dunlop BW, Binder EB, Cubells JF, Goodman MM, Kelley ME, Kinkead B, et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials 2012;13:106.
pubmed: 22776534 pmcid: 3539869 doi: 10.1186/1745-6215-13-106
Gillespie CF, Bradley B, Mercer K, Smith AK, Conneely K, Gapen M, et al. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry. 2009;31:505–14.
pubmed: 19892208 pmcid: 2785858 doi: 10.1016/j.genhosppsych.2009.05.003

Auteurs

Annica J Rasmusson (AJ)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala University Hospital, Entrance 10, Floor 3B, 751 85, Uppsala, Sweden.

Maike Gallwitz (M)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala University Hospital, Entrance 10, Floor 3B, 751 85, Uppsala, Sweden.

Bardia Soltanabadi (B)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala University Hospital, Entrance 10, Floor 3B, 751 85, Uppsala, Sweden.

Diana M Ciuculete (DM)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.

Jonas Mengel-From (J)

The Danish Twin Registry, Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Kaare Christensen (K)

The Danish Twin Registry, Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

Marianne Nygaard (M)

The Danish Twin Registry, Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Mette Soerensen (M)

The Danish Twin Registry, Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

Adrian E Boström (AE)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.

Robert Fredriksson (R)

Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, 75124, Uppsala, Sweden.

Eva Freyhult (E)

Department of Medical Sciences, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Jessica Mwinyi (J)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.

Darina Czamara (D)

Department Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Elisabeth B Binder (EB)

Department Translational Research in Psychiatry, Max-Planck-Institute of Psychiatry, Munich, Germany.

Helgi B Schiöth (HB)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.
Institute of Translational Medicine and Biotechnology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Janet L Cunningham (JL)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala University Hospital, Entrance 10, Floor 3B, 751 85, Uppsala, Sweden. janet.cunningham@neuro.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH